Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease

被引:66
|
作者
Du, Xi-Xun [1 ]
Xu, Hua-Min [1 ]
Jiang, Hong [1 ]
Song, Ning [1 ]
Wang, Jun [1 ]
Xie, Jun-Xia [1 ]
机构
[1] Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China
基金
中国国家自然科学基金;
关键词
6-hydroxydopamine; curcumin; Parkinson's disease; dopaminergic neurons; iron; METAL TRANSPORTER 1; SUBSTANTIA-NIGRA; ANIMAL-MODELS; ANTIOXIDANT; CELLS; DEGENERATION; FLAVONOIDS; CADMIUM; BRAIN; MPTP;
D O I
10.1007/s12264-012-1238-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Curcumin is a plant polyphenolic compound and a major component of spice turmeric (Curcuma longa). It has been reported to possess free radical-scavenging, iron-chelating, and anti-inflammatory properties in different tissues. Our previous study showed that curcumin protects MES23.5 dopaminergic cells from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in vitro. The present study aimed to explore this neuroprotective effect in the 6-OHDAlesioned rat model of Parkinson's disease in vivo. Rats were given intragastric curcumin for 24 days. 6-OHDA lesioning was conducted on day 4 of curcumin treatment. Dopamine content was assessed by high-performance liquid chromatography with electrochemical detection, tyrosine hydroxylase (TH)-containing neurons by immunohistochemistry, and iron-containing cells by Perls' iron staining. The dopamine content in the striatum and the number of TH-immunoreactive neurons decreased after 6-OHDA treatment. Curcumin pretreatment reversed these changes. Further studies demonstrated that 6-OHDA treatment increased the number of iron-staining cells, which was dramatically decreased by curcumin pretreatment. The protective effects of curcumin against 6-OHDA may be attributable to the ironchelating activity of curcumin to suppress the iron-induced degeneration of nigral dopaminergic neurons.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [41] Neuroprotection of edaravone in a 6-hydroxydopamine model of Parkinson's disease
    Li, G.
    Tian, J.
    MOVEMENT DISORDERS, 2006, 21 : S344 - S345
  • [42] Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson's Disease
    Na, Sang J.
    DiLella, Anthony G.
    Lis, Edward V.
    Jones, Keith
    Levine, David M.
    Stone, David J.
    Hess, J. F.
    NEUROCHEMICAL RESEARCH, 2010, 35 (05) : 761 - 772
  • [43] Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease
    Quintero, Elias Matthew
    Willis, Lauren
    Singleton, Rachel
    Harris, Naida
    Huang, Peng
    Bhat, Narayan
    Granholm, Ann-Charlotte
    BRAIN RESEARCH, 2006, 1093 : 198 - 207
  • [44] Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Ghalami, Jamileh
    Mojarad, Tourandokht Baluchnejad
    Mansouri, Monireh
    Khamse, Safoura
    Roghani, Mehrdad
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (01) : 43 - 55
  • [45] Neurorescue Effect of Rosmarinic Acid on 6-Hydroxydopamine-Lesioned Nigral Dopamine Neurons in Rat Model of Parkinson's Disease
    Jieyu Wang
    Huamin Xu
    Hong Jiang
    Xixun Du
    Peng Sun
    Junxia Xie
    Journal of Molecular Neuroscience, 2012, 47 : 113 - 119
  • [46] The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease
    Silvestrin, Roberta Bristot
    de Oliveira, Lucas Fuerstenau
    Batassini, Cristiane
    Oliveira, Alcyr
    Mello e Souza, Tadeu
    JOURNAL OF NEUROSCIENCE METHODS, 2009, 177 (02) : 317 - 321
  • [47] Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease
    Allbutt, Haydn N.
    Henderson, Jasmine M.
    JOURNAL OF NEUROSCIENCE METHODS, 2007, 159 (02) : 195 - 202
  • [48] DEGENERATION OF THE NIGRAL DOPAMINE NEURONS AFTER 6-HYDROXYDOPAMINE INJECTION INTO THE RAT STRIATUM
    ICHITANI, Y
    OKAMURA, H
    MATSUMOTO, Y
    NAGATSU, I
    IBATA, Y
    BRAIN RESEARCH, 1991, 549 (02) : 350 - 353
  • [49] Mechanisms underlying pathological oscillations in the rat 6-hydroxydopamine model of Parkinson's disease
    Escande, M. V.
    Zold, C. L.
    Riquelme, L. A.
    Belforte, J. E.
    Murer, M. G.
    MOVEMENT DISORDERS, 2010, 25 (07) : S339 - S340
  • [50] Neurorescue Effect of Rosmarinic Acid on 6-Hydroxydopamine-Lesioned Nigral Dopamine Neurons in Rat Model of Parkinson's Disease
    Wang, Jieyu
    Xu, Huamin
    Jiang, Hong
    Du, Xixun
    Sun, Peng
    Xie, Junxia
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 47 (01) : 113 - 119